Encapsulated polymerization initiators, polymerization systems and methods using the same

US10087272B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10087272-B2
Application numberUS-201715594590-A
CountryUS
Kind codeB2
Filing dateMay 13, 2017
Priority dateMay 29, 2015
Publication dateOct 2, 2018
Grant dateOct 2, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A polymerizable system includes a curable composition and one or more encapsulated initiator particles. The curable composition can include one or more 1,1-disubstituted alkene compounds and the encapsulated initiator particles can include one or more polymerization initiators encapsulated by a cured composition. The cured composition includes one or more 1,1-disubstituted alkene compounds.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of forming encapsulated initiator matrices comprising: dispersing polymerization initiators in a medium, the polymerization initiators comprising spherical, non-spherical, irregular, angular, textured, or layered particles having an average granulometry of about 0.1 microns to about 1,000 microns; and adding a first polymerizable composition to the medium, the first polymerizable composition comprising one or more 1,1-disubstituted alkene compounds; and wherein the first polymerizable composition polymerizes upon contact with the polymerization initiators to form encapsulated initiator matrices. 2. The method of claim 1 , further comprising the step of terminating residual polymerization of the first polymerizable composition by adding a first anionic polymerization terminator to the medium. 3. The method of claim 2 , wherein the first anionic polymerization terminator comprises a mineral acid, a carboxylic acid, or a combination thereof. 4. The method of claim 1 , wherein the one or more 1,1-disubstituted alkene compounds of the first polymerizable composition comprise low Tg 1,1-disubstituted alkene compounds. 5. The method of claim 1 , wherein the one or more 1,1-disubstituted alkene compounds of the first polymerizable composition comprise a blend of low Tg 1,1-disubstituted alkene compounds and elevated Tg 1,1-disubstituted alkene compounds. 6. The method of claim 1 , wherein the one or more 1,1-disubstituted alkene compounds of the first polymerizable composition are selected from the group consisting of methylene malonates, methylene β-ketoesters, methylene β-diketones, dialkyl disubstituted vinyls, dihaloalkyl disubstituted vinyls, monofunctional, difunctional, or multifunctional monomers, oligomers, or polymers thereof, and combinations thereof. 7. The method of claim 1 , wherein the first polymerizable composition further comprises one or more plasticizers. 8. The method of claim 1 , wherein the medium comprises an aqueous composition. 9. The method of claim 1 , wherein the encapsulated initiator particles rupture when about 0.1 psi or more of mechanical force is applied. 10. The method of claim 1 , further comprising the step of adding a second polymerizable composition to the medium after forming the encapsulated initiator matrices, the second polymerizable composition polymerizing upon contact with the encapsulated initiator matrices to form a shell layer surrounding the encapsulated initiator matrices. 11. The method of claim 10 , wherein the second polymerizable composition comprises one or more 1,1-disubstituted alkene compounds. 12. The method of claim 11 , wherein the one or more 1,1-disubstituted alkene compounds of the first polymerizable composition and the one or more 1,1-disubstituted alkene compounds of the second composition are different. 13. The method of claim 12 , further comprising the step of terminating residual polymerization of the second polymerizable composition by adding a second anionic polymerization terminator. 14. A method of curing a polymerizable system comprising: providing a polymerizable system comprising: a curable composition comprising one or more 1,1-disubstituted alkene compounds; and one or more encapsulated initiator particles, each of the one or more encapsulated initiator particles comprising: one or more polymerization initiators substantially encapsulated by a cured composition formed from one or more 1,1-disubstituted alkene compounds, the one or more polymerization initiators comprising spherical, non-spherical, irregular, angular, textured, or layered particles having an average granulometry of about 0.1 microns to about 1,000 microns; and rupturing the one or more encapsulated initiator particles to initiate polymerization of the curable composition. 15. The method of claim 14 , wherein the step of rupturing the one or more encapsulated initiator particles comprises the application of thermal shock or about 5 psi, or more, of mechanical force to the polymerizable system. 16. The method of claim 14 , wherein the encapsulated initiator particles are mononuclear or polynuclear encapsulated initiator particles. 17. The method of claim 14 , wherein the one or more 1,1-disubstituted alkene compounds of the curable composition and the one or more 1,1-disubstituted alkene compounds of the cured composition are each selected from the group consisting of methylene malonates, methylene β-ketoesters, methylene β-diketones, dialkyl disubstituted vinyls, dihaloalkyl disubstituted vinyls, monofunctional, difunctional, or multifunctional monomers, oligomers, or polymers thereof, and combinations thereof. 18. The method of claim 14 , wherein the one or more 1,1-disubstituted alkene compounds of the curable composition and the one or more 1,1-disubstituted alkene compounds of the cured composition are different. 19. The method of claim 14 , wherein the ratio of the cured composition to the one or more polymerization initiators is a ratio of about 1:1 to about 2:1. 20. The method of claim 14 , wherein the polymerizable system further comprises one or more of a plasticizer, a stabilizer, a thickening agent, and a thixotropic agent.

Assignees

Inventors

Classifications

  • Glass · CPC title

  • Polymerisation catalysts · CPC title

  • B01J13/185Primary

    in an organic phase · CPC title

  • Encapsulated ingredients · CPC title

  • Silicon-containing compounds · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10087272B2 cover?
A polymerizable system includes a curable composition and one or more encapsulated initiator particles. The curable composition can include one or more 1,1-disubstituted alkene compounds and the encapsulated initiator particles can include one or more polymerization initiators encapsulated by a cured composition. The cured composition includes one or more 1,1-disubstituted alkene compounds.
Who is the assignee on this patent?
Sirrus Inc
What technology area does this patent fall under?
Primary CPC classification B01J13/185. Mapped technology areas include Operations & Transport.
When was this patent published?
Publication date Tue Oct 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).